Santos confirms sale by Chinese investor
Chinese shareholder ENN has offloaded a massive stake in oil and gas giant Santos, the ASX-listed group confirmed on Monday
Our Team
Latest
Mesoblast chief raises $US110m, but says no cash concerns
Mesoblast CEO Silviu Itescu says the high-risk biotech has no cash concerns after securing $US110m to meet critical milestones over the next 18-24 months.
Micro-X stroke scanner project gets millions
Aussie share market-listed company Micro-X has won millions in taxpayer funding for the development of emergency stroke detection technology.
Cosmetic injectables plump up SILK’s profit
Cosmetic injectables lifted women’s spirits and ASX-listed beauty business SILK Laser’s fortunes over the busy spring and summer period.
Growing Maggie Beer sales trim first-half loss
Maggie Beer’s growing appeal through COVID-19 and the ‘buy local’ momentum continue to drive the turnaround at her namesake business.
China, SE Asia growth pills for Blackmores
More Blackmores health supplements are being popped in China and South East Asia than in Australia, making up 51 per cent of the vitamin maker’s first-half revenue.
Tyro boss offers ‘faster’ resolution on tech-hit claims
The payments group used its latest growth numbers to hit back at a short-seller targeting its stock.
Bevan Slattery’s HyperOne: Will it take off?
Queensland entrepreneur Bevan Slattery’s $1.5bn project to supercharge Australia’s internet capability has created a stir in tech circles.
The SA company that worked out how to sell pasta to Italy
Australia’s biggest pasta-making business sowed its first seeds of national domination 30 years ago.
Behind a billion-dollar psychedelic bet
Christian Angermayer is among a growing breed of new-age billionaires around the world investing in ‘moonshot’ ideas and he has now turned his attention to Australia.
Original URL: https://www.theaustralian.com.au/author/valerina-changarathil/page/119